🇺🇸 FDA
Patent

US 7649115

MAO-B inhibitors useful for treating obesity

granted A61PA61P25/00A61P3/00

Quick answer

US patent 7649115 (MAO-B inhibitors useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jenrin Discovery, LLC
Grant date
Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P25/00, A61P3/00, A61P3/04, A61P3/10